Patient Capital Management, LLC
Patient Capital Management, LLC is an SEC-registered investment adviser based in Baltimore, Maryland, founded in 2020 by Samantha McLemore. The firm is woman-owned and independent, having acquired Miller Value Partners' Opportunity Equity business. It manages approximately $2.1 billion in assets and employs a team of 10 professionals, serving institutional investors, mutual funds, high net worth clients, and private funds. The firm leverages the decades-long experience of its founder and team to deliver long-term value-oriented investment strategies.
Investment Strategy
Patient Capital Management employs an opportunistic, long-term, value-oriented equity strategy. Their approach is grounded in a value-driven, research-intensive investment process, actively selecting securities that trade at a discount to intrinsic value. The firm pursues outperformance over the long term by maintaining flexibility and patience in investment decision-making, serving mutual funds, institutions, and high net worth individuals, and offering customized advisory services as needed. The investment philosophy and process draws on decades of successful implementation by the firm's leadership.
Latest 13F Filing Activity
Patient Capital Management, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 40 equity positions with a total 13F market value of $2B. The fund increased holdings in Unitedhealth Group Inc., Qxo Inc., Coinbase Global Inc. among other positions. Patient Capital Management, LLC reduced exposure to General MTRS Co., Biogen Inc., New Fortress Energy Inc. among others.
Top Holdings
Equity Positions (40)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
Q QXO | QXO INC | 6.36% | $140.9M | 6,542,202 | $15.77 | $21.54 | +$42.3M |
A AMZN | AMAZON COM INC | 5.58% | $123.6M | 563,482 | $132.99 | $219.39 | +$14.4M |
C C | CITIGROUP INC | 5.17% | $114.5M | 1,345,717 | $45.49 | $85.12 | +$14.8M |
G GOOGL | ALPHABET INC | 4.88% | $108.0M | 613,053 | $123.78 | $176.23 | +$14.4M |
R RPRX | ROYALTY PHARMA PLC | 4.86% | $107.7M | 2,987,988 | $27.65 | $36.03 | +$15.1M |
Industry Allocation
Investment Team (2)
| Name | Role | Location | |
|---|---|---|---|
T Tyler Grason | Senior Research Analyst | Baltimore, MD , United States | |
 | Assistant Portfolio Manager | Baltimore, MD , United States |